Jing Wang, PhD

Co-Founder & CEO, Board Member

• Industry experience covering all phases of small-molecule drug development from discovery to commercialization since 2006.
• Various R&D leadership roles at Curis, TESARO/GSK, & Constellation.
• Led the translational development of ZEJULA™ for its NDA/CDx co-filing, life cycle management, and commercialization.
• PhD from Harvard Medical School, thesis research focused on neurodegeneration.